Yahoo Web Search

Search results

    • Profiting from pandemics - Nature Biotechnology

      Nature· 1 day ago

      It's most likely that established vaccine developers, such as London-based GlaxoSmithKline and Sanofi Aventis of Paris, would pump out stockpiles of any pandemic flu vaccine, but it is the small ...